Drug Profile
Research programme: biotherapeutics - Kidswell Bio
Alternative Names: GND-002; GND-003; GND-005Latest Information Update: 28 Jun 2023
Price :
$50
*
At a glance
- Originator Gene Techno Science
- Developer Gene Techno Science; Kidswell Bio
- Class Antibodies; Antineoplastics; Eye disorder therapies
- Mechanism of Action Immunomodulators; Receptor activity-modifying protein 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer; Eye disorders
- Discontinued Cardiovascular disorders
Most Recent Events
- 28 Jun 2023 No recent reports of development identified for preclinical development in Eye-disorders in Japan
- 28 Dec 2021 No recent reports of development identified for preclinical development in Cancer in Japan (Parenteral)
- 01 Jul 2021 Gene Techno Science is now called Kidswell Bio